LONG-TERM CLINICAL COURSE OF THE FIRST 250 PATIENTS TREATED WITH SELEXIPAG IN REAL-WORLD SETTINGS FROM THE SPHERE REGISTRY (SELEXIPAG:THE USERS DRUG REGISTRY)